Esophagitis
40
4
5
23
Key Insights
Highlights
Success Rate
85% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.0%
4 terminated out of 40 trials
85.2%
-1.3% vs benchmark
10%
4 trials in Phase 3/4
22%
5 of 23 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 23 completed trials
Clinical Trials (40)
Domperidone in Treating Patients With Gastrointestinal Disorders
Protonix Treatment of Maintenance of Healing in Pediatric Participants Aged 1-11 Years and 12-17 Years
The Johns Hopkins Heartburn Center Registry
Deep-sea Fish Oil for Prevention of Acute Radiation-induced Esophagitis
Esophagus-sparing Radiotherapy for Metastatic Spinal Cord Compression.
The Bacterial Composition of the Stomach in Reflux Disease
The Effect of Physiotherapy on Post POEM Reflux
Study to Identify Non-Invasive Markers of Gastrointestinal Allergy
Clinical Investigation to Assess the Acid Neutralisation Activity of a Calcite Chewing Gum
Effects of Intravenous GC4419 on the Incidence and Severity of Esophagitis Due to Chemoradiotherapy for Lung Cancer
A Study of Anaprazole Sodium Enteric-coated Tablets in the Treatment of Reflux Esophagitis
Twenty Four Hour Ambulatory pH & Impedance Testing: Normative Data for Indian Population
Study of Dietary Patterns and Food Diversity in Russian GERD Patients
Management of Esophagitis Following Repair of Esophageal Atresia
Esophageal Monitoring Device for Assessing Mucosal Impedance
Study of Epigallocatechin-3-gallate (EGCG) for Esophagus Protection in Patients With Lung Cancer Receiving Radial Radiotherapy
The Role of HIF-2a in the Pathogenesis of Reflux Esophagitis
Sensory Evaluation of Oral Nutrition Supplements in Patients at Risk for Mucositis Undergoing Cancer Treatment
CYP2C19 Genotype Predictor of Gastric Acid Suppression
Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer